Hyperfine (NASDAQ:HYPR) Trading Up 12.7% – What’s Next?

Hyperfine, Inc. (NASDAQ:HYPR)’s stock price traded up 12.7% during mid-day trading on Monday . The stock traded as high as $1.27 and last traded at $1.24. 420,808 shares traded hands during trading, an increase of 204% from the average session volume of 138,523 shares. The stock had previously closed at $1.10.

Hyperfine Stock Up 12.7 %

The company has a fifty day simple moving average of $0.96 and a 200-day simple moving average of $1.00. The firm has a market cap of $90.46 million, a P/E ratio of -2.18 and a beta of 0.92.

Hyperfine (NASDAQ:HYPR) last released its quarterly earnings results on Tuesday, November 12th. The company reported ($0.14) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.14). Hyperfine had a negative return on equity of 57.54% and a negative net margin of 309.42%. The business had revenue of $3.64 million during the quarter, compared to analyst estimates of $3.40 million. During the same quarter in the previous year, the company posted ($0.15) earnings per share. As a group, research analysts forecast that Hyperfine, Inc. will post -0.57 EPS for the current year.

Hedge Funds Weigh In On Hyperfine

An institutional investor recently raised its position in Hyperfine stock. Geode Capital Management LLC grew its holdings in Hyperfine, Inc. (NASDAQ:HYPR) by 18.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 624,520 shares of the company’s stock after acquiring an additional 98,335 shares during the period. Geode Capital Management LLC owned about 0.86% of Hyperfine worth $675,000 as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 15.03% of the company’s stock.

Hyperfine Company Profile

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.